Mode of Action of Maintenance Immunotherapy Therapy With the TLR-9 Agonist MGN1703 in Metastatic Colorectal Carcinoma: The Phase III IMPALA Study
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p173
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
BMJ